{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T05:54:57Z","timestamp":1723182897432},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":["www.echorespract.com"],"crossmark-restriction":true},"short-container-title":["Echo Res Pract"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1530\/erp-17-0021","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T00:20:09Z","timestamp":1499473209000},"page":"K11-K15","update-policy":"http:\/\/dx.doi.org\/10.1530\/erp\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["A rash with a heavy heart"],"prefix":"10.1186","volume":"4","author":[{"given":"Sergio","family":"Barros-Gomes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niyada","family":"Naksuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragan","family":"Jevremovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector R","family":"Villarraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,7]]},"reference":[{"key":"ref101","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10741-014-9464-5","article-title":"Natural history and therapy of AL cardiac amyloidosis","volume":"20","year":"2015","journal-title":"Heart Failure Reviews"},{"key":"ref181","first-page":"456","article-title":"Deformation patterns in genotyped patients with hypertrophic cardiomyopathy","volume":"15","year":"2014","journal-title":"European Heart Journal: Cardiovascular Imaging"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jcmg.2016.04.008","article-title":"Prognosis of light chain amyloidosis with preserved LVEF","volume":"10","year":"2017","journal-title":"JACC Cardiovascular Imaging"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/qjmed\/91.2.141","article-title":"The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement","volume":"91","year":"1998","journal-title":"QJM"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jcmg.2016.04.008","article-title":"Prognosis of light chain amyloidosis with preserved LVEF","volume":"10","year":"2017","journal-title":"JACC Cardiovascular Imaging"},{"key":"ref81","first-page":"456","article-title":"Deformation patterns in genotyped patients with hypertrophic cardiomyopathy","volume":"15","year":"2014","journal-title":"European Heart Journal: Cardiovascular Imaging"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.blre.2012.03.001","article-title":"What do I need to know about immunoglobulin light chain (AL) amyloidosis?","volume":"26","year":"2012","journal-title":"Blood Reviews"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.jacc.2009.12.040","article-title":"Infiltrative cardiovascular diseases: cardiomyopathies that look alike.","volume":"55","year":"2010","journal-title":"Journal of the American College of Cardiology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.jacc.2007.08.028","article-title":"Evaluation and management of the cardiac amyloidosis","volume":"50","year":"2007","journal-title":"Journal of the American College of Cardiology"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jacc.2005.10.061","article-title":"Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy","volume":"47","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.jacc.2009.12.040","article-title":"Infiltrative cardiovascular diseases: cardiomyopathies that look alike.","volume":"55","year":"2010","journal-title":"Journal of the American College of Cardiology"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy.","volume":"68","year":"2016","journal-title":"Journal of the American College of Cardiology"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements.","volume":"30","year":"2012","journal-title":"Journal of Clinical Oncology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy.","volume":"68","year":"2016","journal-title":"Journal of the American College of Cardiology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.blre.2012.03.001","article-title":"What do I need to know about immunoglobulin light chain (AL) amyloidosis?","volume":"26","year":"2012","journal-title":"Blood Reviews"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.jacc.2007.08.028","article-title":"Evaluation and management of the cardiac amyloidosis","volume":"50","year":"2007","journal-title":"Journal of the American College of Cardiology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements.","volume":"30","year":"2012","journal-title":"Journal of Clinical Oncology"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jacc.2005.10.061","article-title":"Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy","volume":"47","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10741-014-9464-5","article-title":"Natural history and therapy of AL cardiac amyloidosis","volume":"20","year":"2015","journal-title":"Heart Failure Reviews"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/qjmed\/91.2.141","article-title":"The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement","volume":"91","year":"1998","journal-title":"QJM"}],"container-title":["Echo Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1530\/ERP-17-0021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T09:52:52Z","timestamp":1702461172000},"score":1,"resource":{"primary":{"URL":"https:\/\/echo.biomedcentral.com\/articles\/10.1530\/ERP-17-0021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,7]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,7,28]]},"published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.1530\/ERP-17-0021"],"URL":"https:\/\/doi.org\/10.1530\/erp-17-0021","relation":{},"ISSN":["2055-0456","2055-0464"],"issn-type":[{"value":"2055-0456","type":"print"},{"value":"2055-0464","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,7]]}}}